Chemistry Analyzer Financing for the AU480 and cobas c 311

Finance up to $200,000

From a $40,000 refurbished cobas c 311 to a fully configured $200,000 AU480, we fund the analyzer, ISE module, reagents, and LIS interface in one amount.

Rates from 5.49% APR

Qualified practices start at 5.49% APR over 24 to 84 months, priced to your credit and time in practice and quoted firm once we see the file.

New or refurbished, same terms

A refurbished AU480 at half the price of new is funded on identical terms. We handle Beckman Coulter, Roche, and refurbisher invoices.

Deferred payments during CLIA setup

We can defer your first payment while you complete CLIA certification, validation, and training, so the note starts when the lab is live and billing.

The case for in-house chemistry is part clinical, part financial. Clinically, a same-day comprehensive metabolic panel changes how you manage a diabetic, a patient on diuretics, or a nephrology follow-up. You adjust today instead of calling the patient back after the reference lab reports in two days. Financially, every panel you run in-house is a panel you bill under your own CLIA certificate rather than paying a send-out lab and capturing nothing. The AU480 and cobas c 311 cover the bread and butter: 80053 comprehensive metabolic panel, 80048 basic metabolic panel, 80061 lipid panel, 83036 hemoglobin A1c, liver function tests, renal panels, and electrolytes through the ISE module. To do this you need a CLIA certificate at the right complexity level, reagent packs, calibration, and daily quality control tracked on Levey-Jennings charts, plus an interface to your LIS or EHR so results flow without hand entry. That is real operational lift, but it is well-trodden. Thousands of clinics run these analyzers. Once the workflow is set, the marginal cost of a panel is reagent and tech time, and the reimbursement stays in your practice instead of leaving with the courier.

Chemistry analyzer deals we funded recently:

• $88,000 Beckman Coulter AU480 for a multi-specialty clinic in Houston, 8 years in practice, 726 credit score. Approved at 5.74% APR over 60 months with 10% down. Same-day chemistries stayed in the building instead of going to a send-out lab.
• $58,000 refurbished Roche cobas c 311 for a primary care group in San Antonio, 6 years in practice, 697 score. 6.49% APR over 48 months, zero down.
• $142,000 new AU480 with ISE and sample handling for a nephrology practice in Dallas, 15 years in practice, 755 score. 5.49% APR over 72 months, 5% down.
• $47,500 refurbished cobas c 311 for an urgent care startup in Austin, two years in, 666 score (challenged credit). Funded at 6.99% APR over 60 months with 15% down.

The Houston AU480 makes the point. After 10% down, financing about $79,000 over 60 months at 5.74% runs roughly $1,520 a month. The break-even is a volume question, not a rate question. Individual chemistry CPTs reimburse modestly under the Clinical Laboratory Fee Schedule, a lipid panel and a metabolic panel each land in the low tens of dollars, but a multi-specialty clinic runs hundreds of panels a month, and every one you previously sent out was pure lost revenue. Add reagent cost and tech time and the analyzer still clears its payment on a few dozen panels a week, with the rest dropping to the bottom line. The faster turnaround also drives more testing at the point of care, which compounds the volume.

Section 179 applies cleanly to lab equipment. The full price of a qualifying analyzer can generally be expensed in the year it is placed in service under the current $2.5 million cap, and 100% bonus depreciation is in effect for equipment placed in service in 2026. A $142,000 AU480 installed before year-end can often be written off in full that tax year rather than depreciated over its useful life. Confirm the treatment with your CPA, but on a six-figure analyzer the first-year deduction is a substantial offset.

Chemistry analyzers cover a wide price range, so the file scales with the ticket. A refurbished cobas c 311 under about $75,000 often funds app-only with a single-page application and no tax returns. A fully configured new AU480 in the six figures may call for basic financials, but nothing burdensome. Either way we take the application to more than 500 lenders, several of whom specialize in laboratory and diagnostic equipment, and we shop it instead of sending it to one desk.

We fund new and refurbished analyzers on the same terms, which matters when a refurbished AU480 at half the price of new is the smart buy. Invoices from Beckman Coulter, Roche Diagnostics, and established lab-equipment refurbishers are all straightforward for us, and we can include the ISE module, sample handling, initial reagents, and LIS interface work in the amount financed. Terms run 24 to 84 months, and we can defer the first payment while you complete CLIA setup, validation, and staff training, so you are not paying before the lab is live. Rates start from 5.49% APR for qualified practices and are priced by credit, time in practice, and the equipment. Challenged credit and startup clinics go to lenders who underwrite the practice and the lab economics, not just the score.

Can I finance the reagents and LIS interface too?

Yes. The ISE module, sample handling, initial reagent packs, installation, and LIS or EHR interface work can all be rolled into the amount financed alongside the analyzer.

Do you finance refurbished analyzers?

Yes, on the same terms as new. A refurbished Roche cobas c 311 or Beckman Coulter AU480 is a common way to control cost, and we fund refurbisher invoices readily.

Can payments wait until my CLIA lab is running?

Usually. We can defer the first payment while you complete CLIA certification, method validation, and staff training, so you are not paying before the analyzer is billing.

What credit do I need for a six-figure analyzer?

There is no single cutoff. We have funded new AU480 systems for established practices and refurbished units for startup urgent cares in the 660s. Challenged credit goes to lenders who underwrite the lab economics. Rates start from 5.49% APR for qualified practices.